CNR Institutional Research Information System

BERGHELLA, ANNA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.032
NA - Nord America 1.344
EU - Europa 405
SA - Sud America 373
AF - Africa 34
OC - Oceania 3
Totale 4.191
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.297
SG - Singapore 891
CN - Cina 403
BR - Brasile 307
HK - Hong Kong 272
VN - Vietnam 186
FR - Francia 141
IT - Italia 107
KR - Corea 61
IN - India 42
JP - Giappone 41
BD - Bangladesh 33
DE - Germania 28
AR - Argentina 27
GB - Regno Unito 25
NL - Olanda 24
CA - Canada 22
ID - Indonesia 15
IQ - Iraq 15
MX - Messico 14
FI - Finlandia 13
EC - Ecuador 12
IL - Israele 12
SE - Svezia 12
ES - Italia 8
PK - Pakistan 8
TR - Turchia 8
ZA - Sudafrica 8
KE - Kenya 7
MA - Marocco 7
PE - Perù 7
UA - Ucraina 7
JO - Giordania 6
MY - Malesia 6
PL - Polonia 6
SA - Arabia Saudita 6
VE - Venezuela 6
IE - Irlanda 5
KZ - Kazakistan 5
RU - Federazione Russa 5
CL - Cile 4
CO - Colombia 4
HR - Croazia 4
LB - Libano 4
AT - Austria 3
AU - Australia 3
ET - Etiopia 3
JM - Giamaica 3
LT - Lituania 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
BE - Belgio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
KG - Kirghizistan 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CU - Cuba 1
DK - Danimarca 1
GE - Georgia 1
GR - Grecia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
NP - Nepal 1
RO - Romania 1
RS - Serbia 1
SD - Sudan 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
TW - Taiwan 1
Totale 4.191
Salva come PNG Salva come JPEG
Città #
Santa Clara 718
Singapore 522
Hong Kong 269
Hefei 147
San Jose 136
Lauterbourg 100
Beijing 98
Ho Chi Minh City 66
Ashburn 62
Los Angeles 57
Seoul 57
Hanoi 46
São Paulo 32
Tokyo 31
Dallas 27
New York 27
Buffalo 22
Da Nang 12
Helsinki 12
Stockholm 10
Chennai 9
Montreal 9
Baghdad 8
Frankfurt am Main 8
Milan 8
Minamishinagawa 8
Orem 8
Rio de Janeiro 8
Dhaka 7
Mumbai 7
Belo Horizonte 6
Bengaluru 6
Düsseldorf 6
Haiphong 6
Johannesburg 6
Kuala Lumpur 6
Nairobi 6
Nuremberg 6
Quito 6
Brooklyn 5
Campinas 5
Charlotte 5
Dublin 5
Porto Alegre 5
Riyadh 5
Rome 5
Amman 4
Atlanta 4
Biên Hòa 4
Brasília 4
Casablanca 4
Council Bluffs 4
Guangzhou 4
Jakarta 4
London 4
Marigliano 4
Newark 4
Phoenix 4
Shanghai 4
Thái Bình 4
Toronto 4
Warsaw 4
Addis Ababa 3
Almaty 3
Araruama 3
Can Tho 3
Chicago 3
Contagem 3
Curitiba 3
Fort Worth 3
Guayaquil 3
Hangzhou 3
Houston 3
Kyiv 3
Mexico City 3
Montevideo 3
Nanjing 3
Nha Trang 3
Ourinhos 3
Pescara 3
Portsmouth 3
Seattle 3
Serra 3
São Carlos 3
São José dos Campos 3
Wuhan 3
Xi'an 3
Asunción 2
Atibaia 2
Baguio City 2
Baku 2
Bauru 2
Belém 2
Bishkek 2
Bogotá 2
Boston 2
Brussels 2
Buenos Aires 2
Cagliari 2
Camaçari 2
Totale 2.785
Salva come PNG Salva come JPEG
Nome #
Classification of cancer stage using the immune system. 96
Are Immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement? 88
Analisi longitudinale delle sottopopolazioni T-linfocitarie nella Sclerosi Multipla. 84
Personalized Prevention Strategies to Defeat Cancer 81
Immunological mechanisms in the establishment and progression of colon cancer. 69
Cytokines in colon cancer patients. 65
The definition of a panel of clinical biomarkers of homeostasis: a new promising tool for prevention and treatment of chronic-degenerative 65
CD30 antigen: not a physiological marker for TH2 cells but animportant costimulator molecule in the regulation of the balance between TH1/TH2 response 60
Redox, immune and genetic biomarker system for personalized treatments in colorectal cancer 58
Farmaci neurolettici e produzione di linfochine "in vitro" in pazienti schizofrenici. 57
CD30 Molecule, the Immune System and Multiple Sclerosis. CD30 the still unknown molecule involved in the cell contact-dependent suppression of T cells by dendritic cells, which mediated signals responsible for maintainig the physiological balance between: dendritic and T regulatory cells, the immune responses and central and peripheral tolerance. 57
Tumor stage and serum levels of sIL-2R in colon cancer patients 55
CD30 Molecule, The Immune System and Multiple Sclerosis. 55
Day of Immunology 2015 54
The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender-specific Biomarkers in Personalized Cancer Therapy 53
Cytokines in colon cancer patients: Disease markers in cancer therapy. Il-2 receptor 51
The discovery of how gender influences age immunological mechanisms in health and disease, and the identification of ageing gender-specific biomarkers, could lead to specifically tailored treatment and ultimately improve therapeutic success rates. 50
IL-8 involvement in immune disregulation of cancer patients 48
Gender-Specific Cytokine Pathways, Targets, and Biomarkers for the Switch from Health to Adenoma and Colorectal Cancer. 47
Immunological directives for biotherapy improvement in the treatment of colorectal cancer. 46
Livelli serici di IL-2, sIL-2R, IL-6 and TNF nella schizofrenia: uno studio controllato 45
Ageing gender-specific "Biomarkers of Homeostasis", to protect ourselves against the diseases of the old age 45
A gender-related action of IFNß-therapy was found in multiple sclerosis. 45
The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy 45
Medical research news in the understanding, diagnosis, treatment, cure or prevention of cancer disease: "ARE IMMUNOLOGICAL MECHANISMS INVOLVED IN COLON CANCER AND ARE THEY POSSIBLE MARKERS FOR BIOTHERAPY IMPROVEMENT?" 45
Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy 44
Medical research news in the understanding, diagnosis, treatment, cure or prevention of human disease: "Ageing gender-specific targets/biomarkers for the identification of drugs with specific gender-related action and more appropriate therapeutic strategies." 44
Identification of a recombination event by DNA heteroduplex in a bone marrow transplant familial study 42
IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer 42
Correlazione tra gli alleli DPB1 ed MLC nel trapianto di rene 42
Novel Prognostic Biomarkers for Personalized Cancer Treatment 40
The immunological implications of gene alterations in the progression of colorectal cancer: indications for prognosis, treatment and tumor understanding. 40
Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer 40
Soluble CD30: a biomarker for evaluating the clinical risk versus benefit of IFNbeta1A treatment in multiple sclerosis patients. 40
Prognostic indices for the early classification of colon cancer stage 39
Hypothesis of the variable clinical response to immunotherapeutic treatments in colon cancer patients 38
Prognostic indices for the early classification of colon cancer stage. 38
Soluble IL-2 Receptor and proliferative responses to IL-2+anti-CD3 monoclonal antibody in colon cancer 38
IFNbeta therapy dose makes functional efficiency differences in Multiple Sclerosis patients 38
The study of patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancer. 38
Immunological mechanisms in the establishment and progression of colon caner 38
Bcl-2 and drugs used in the treatment of cancer: New strategies of biotherapy which should not be underestimated. 37
Progression mechanisms in colon cancer: soluble interleukin2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and 37
Marcatori di linfociti nell'anziano in emodialisi periodica 36
Cancer establishment and progression 36
L'ipotesi autoimmunitaria della schizofrenia. Recettore solubile dell'Interleuchina 2 e Tumor Necrosis Factor. 36
Colon cancer: sIL-2R and correlated mechanisms 35
MLC test and/or DNA typing in Bone Marrow transplantation 35
IFNbeta therapy dose makes functional efficiency differences in Multiple Sclerosis patienst 35
Production of cytokines in schizophrenic patients: correlation with pharmacological treatment 34
Immunological implications of alterations in the c-ki-ras and p53 gene in the stepwise progression of colorectal cancer: indications for the improvement of prognosis, biotherapy treatment and tumor biology understanding. 34
Immune disregulation in colon cancer 34
HLA antigens in multiple sclerosis 33
IL-6 and NK activity in colorectal cancer. 33
Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression 33
Serum factor may interact with T8+ cells during the clinical course of multiple sclerosis. 33
Colon cancer: hypotesis of progression mechanism 33
HLA and policystic disease: a negative association 33
Andamento dell'HBSAg e dell'HbsAb nei pazienti e nel personale di alcune centrali dialitiche. 32
Cell cycle control in cellular homeostasis during the immune response: interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules 32
Cytokines in Schizophrenia 32
Peripheral blood immunological parameters for use as markers of pre-invasive to invasive colorectal cancer 32
Relationships between the activity of MMPI/TIMPI enzymes and the TH1/TH2 cytokine network 32
Detection of circulating ICAM-1 and soluble IL-2 receptor in serum of colon cancer patients 32
DETECTION OF CIRCULATING ICAM-1 AND SOLUBLE IL-2 RECEPTOR IN SERUM OF COLORECTAL CANCER PATIENTS 31
In vitro evaluation of the immunological response in colon cancer patients: effects of IL-2, IL-4 and anti-CD3MoAb 31
Blockade of N Methyl D-Aspartate receptor prevents Hypoxic Neuronal dath and Cytokine release. 31
Monitoraggio serico di sIL-2R nel trapianto renale. 31
Relationships between the activity of MMP1/TIMP1 enzymes and the TH1/TH2 cytokine network. 31
Functional and phenotipic analysys of lymphocytes from tumor-draining lymph nodes in colon neoplasms 30
IFNbeta-1a treatment and reestablishment of TH1 regulation in MS patients: dose effects. 30
Simultaneous measurement of sCEA and TIMP1 serum levels for use as pre-invasive to invasive markers of colorectal cancer. 30
The TH1 and TH2 cytokine network in healthy subjects: suggestions for experimental studies to create prognostic and diagnostic indices for biotherapeutic treatments 30
Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions 30
Identification of recombination event by DNA heteroduplex in a bone marrow transplant familiar study 29
Presence in multiple sclerosis of serum factors wich modulate "in vitro" reactivity to T8 moAb. 29
TNF, IL-6 and soluble IL-2 Receptor in colorectal cancer: comparison of "in vitro" and "in vivo" findings 29
Serum levels of IL-2, soluble IL-2R, TNF, Il-6 in schizophrenic patients: a controlled study 29
Cultured hyppocampal neurons may secrete a compound inhibiting PHA-induced lymph cells proliferation 29
Identification of a serum factor interacting with a subset of OKT8+ cells in M.S. 29
T-Lymphocyte subsets modifications in multiple sclerosis: correlation with clinical disease activity. 28
CD30: an important costimulator molecule in the regulation of the balance between TH1/TH2 response 28
HLA-DR6 antigen in Schizophrenia 28
Negative association of the HLA-DR 6 antigen in Schizophrenia. 28
The Significance of an increase in soluble interleukin- 2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 o TH2 and back. 28
Inibizione dei neuroni centrali sulla risposta proliferativa delle cellule mononucleate di sangue periferico 28
Serum levels of soluble IL-2 receptor in cancer patients. 28
The sCEA molecule suppressive role in NK and TH1 cell functions in colorectal cancer 28
Prognostic Significance of immunological evaluation in colorectal cancer. 27
Loci Ia-LIKE e risposta alle malattie 27
Cytokine contribution to the repair processess and homeostasis recovery following anoxic insult: a possible IFN regulating role in IL1 neurotoxic action in physiological or damaged CNS 27
Disease markers in cancer patients: IL-2 receptor 26
Role of HLA-restricted T cells in colorectal cancer 26
Carcinoembryonic antigen and soluble interleukin-2 receptor in colon cancer 26
Identification of factors interacting with a subset of T8+ cells. 26
Disease Stage Prognostic Indices in the Early Clinical Screening of Colorectal Cancer Patients. 25
Soluble Lymphocyte activation molecules in cancer 25
The Directory of On-going Cancer Research in the European Union 25
The TH1 And TH2 cytokine network in healthy subjects: suggestions for experimental studies to create prognostic and diagnostic indices for biotherapeutic treatments. 24
The NMDA receptor antagonist AP5 reduces IL-1beta release in anoxic neuronal cultures 24
Totale 3.895
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.016
article - articoli 8.744
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.073
Totale 22.833
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202417 0 0 0 0 0 0 0 0 1 2 7 7
2024/20251.841 4 18 107 68 618 110 22 44 43 87 372 348
2025/20262.349 115 206 236 345 383 174 346 126 154 166 98 0
Totale 4.207